Boston Partners’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-313,782
| Closed | -$75.3M | – | 703 |
|
|
2021
Q4 | $75.3M | Sell |
313,782
-18,807
| -6% | -$4.51M | 0.09% | 216 |
|
|
2021
Q3 | $94.1M | Buy |
332,589
+11,506
| +4% | +$3.26M | 0.12% | 208 |
|
|
2021
Q2 | $111M | Buy |
321,083
+15,047
| +5% | +$5.21M | 0.14% | 196 |
|
|
2021
Q1 | $85.6M | Buy |
306,036
+13,221
| +5% | +$3.7M | 0.11% | 214 |
|
|
2020
Q4 | $71.7M | Buy |
292,815
+950
| +0.3% | +$233K | 0.11% | 210 |
|
|
2020
Q3 | $82.8M | Sell |
291,865
-12,909
| -4% | -$3.66M | 0.15% | 183 |
|
|
2020
Q2 | $81.5M | Sell |
304,774
-34,640
| -10% | -$9.27M | 0.15% | 181 |
|
|
2020
Q1 | $107M | Sell |
339,414
-1,061,842
| -76% | -$336M | 0.21% | 138 |
|
|
2019
Q4 | $416M | Sell |
1,401,256
-111,192
| -7% | -$33M | 0.55% | 59 |
|
|
2019
Q3 | $353M | Sell |
1,512,448
-57,411
| -4% | -$13.4M | 0.48% | 64 |
|
|
2019
Q2 | $367M | Buy |
1,569,859
+647,141
| +70% | +$151M | 0.48% | 70 |
|
|
2019
Q1 | $218M | Buy |
922,718
+746,711
| +424% | +$177M | 0.29% | 102 |
|
|
2018
Q4 | $53M | Buy |
176,007
+3,920
| +2% | +$1.18M | 0.08% | 230 |
|
|
2018
Q3 | $60.8M | Sell |
172,087
-90,040
| -34% | -$31.8M | 0.07% | 227 |
|
|
2018
Q2 | $76.1M | Buy |
+262,127
| New | +$76.1M | 0.09% | 205 |
|